TearLab Corporation (NASDAQ:TEAR) is scheduled to issue its quarterly earnings data after the market closes on Monday, August 14th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter.

TearLab Corporation (NASDAQ:TEAR) last announced its quarterly earnings results on Monday, May 15th. The medical research company reported ($0.82) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.75) by $0.07. The company had revenue of $6.70 million during the quarter, compared to analysts’ expectations of $7.02 million. The business’s revenue for the quarter was down 1.5% compared to the same quarter last year. During the same period last year, the firm earned ($0.21) EPS. On average, analysts expect TearLab Corporation to post $-2.82 EPS for the current fiscal year and $-1.39 EPS for the next fiscal year.

Shares of TearLab Corporation (NASDAQ:TEAR) opened at 2.43 on Monday. The company has a 50 day moving average price of $1.95 and a 200-day moving average price of $3.15. The stock’s market cap is $13.94 million. TearLab Corporation has a one year low of $1.55 and a one year high of $8.78.

A number of brokerages have recently issued reports on TEAR. HC Wainwright restated a “buy” rating and set a $4.00 price target on shares of TearLab Corporation in a report on Tuesday, May 16th. Zacks Investment Research downgraded shares of TearLab Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, May 16th. Finally, Rodman & Renshaw cut their price target on shares of TearLab Corporation from $12.00 to $4.00 and set a “buy” rating for the company in a report on Tuesday, May 16th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $5.05.

WARNING: This article was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/08/07/tearlab-corporation-tear-scheduled-to-post-quarterly-earnings-on-monday.html.

TearLab Corporation Company Profile

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc, develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care.

Earnings History for TearLab Corporation (NASDAQ:TEAR)

Receive News & Ratings for TearLab Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TearLab Corporation and related companies with MarketBeat.com's FREE daily email newsletter.